Recent Finacing
Recent Raise
ITabMed is a clinical-stage biotech in Shanghai developing the patented iTAb™ platform to generate bi- and tri-specific T cell engagers, advancing multiple candidates including two Phase I programs.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at ITabMed.
